Literature DB >> 33956266

Luminescent Analysis of Blood Serum for Diagnostics of Pathological and Pre-Pathological States of Cancer Patients.

Marina Bondarenko1, Olga Zaytseva1, Valeriya Trusova2, Anton Moiseenko3, Aleksey Rukin1, Tetyana Utytskykh1, Oksana Morozova1.   

Abstract

This study is devoted to the development of a methodological approach to mathematical analysis and data interpretation of blood serum phosphorescence intensity in cancer patients for determining the pathological states and differential diagnostics of oncological process stages. The purpose of the study is blood serum phosphorescence research in patients with colorectal cancer (CRC) and stomach adenocarcinoma (SAC) and determination of the ultraweak luminescence role for diagnostics of the disease, determining its stages, control of pathogenetic therapy efficiency and forecast of recovery. The values of phosphorescence intensity of blood serum films in patients with CRC and SAC are significantly higher than the corresponding values for the control group. Contrary to the absolute intensity, the relative intensity increase compared to the control group is much more informative for oncoprocess diagnostics, since it exhibits three times increase even at the first stage of tumoral process. Serum phosphorescence intensity continues to increase with progressing of the disease. As the result of our study, the relative intensity increase compared to the first stage can be recommended as an informative indicator for differential diagnostics of oncological process stages. As a conclusion, determination of blood serum phosphorescence intensity can be considered as a sensitive and specific diagnostic method in oncology. With a correct methodological approach to data processing and interpretation, this method can be used in clinical practice for determining the oncopathological states, differential diagnostics of oncoprocess stages and diagnostics of precancer changes, which precede tumoral process development.

Entities:  

Keywords:  Blood serum phosphorescence; Cancer stages; Differential diagnostics; Mathematical analysis; Methodological approach; Oncoprocess; Relative intensity

Mesh:

Year:  2021        PMID: 33956266     DOI: 10.1007/s10895-021-02744-x

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  13 in total

Review 1.  Genomic stability and tumorigenesis.

Authors:  Oliver Sieber; Karl Heinimann; Ian Tomlinson
Journal:  Semin Cancer Biol       Date:  2005-02       Impact factor: 15.707

2.  Modulatory effects of non-steroidal anti-inflammatory drugs on the luminol and lucigenin amplified chemiluminescence of equine neutrophils.

Authors:  H Benbarek; A Ayad; G Deby-Dupont; L Boukraa; D Serteyn
Journal:  Vet Res Commun       Date:  2011-10-21       Impact factor: 2.459

3.  Cancer-associated mutations in healthy individuals: assessing the risk of carcinogenesis.

Authors:  Ignacio A Rodriguez-Brenes; Natalia L Komarova; Dominik Wodarz
Journal:  Cancer Res       Date:  2014-01-22       Impact factor: 12.701

Review 4.  New research in kidney cancer, ASCO-GU 2017.

Authors:  Naveen Basappa; Frederic Pouliot
Journal:  Can Urol Assoc J       Date:  2017-06       Impact factor: 1.862

5.  Chemiluminescence detection of ATP release from red blood cells upon passage through microbore tubing.

Authors:  J Edwards; R Sprung; R Sprague; D Spence
Journal:  Analyst       Date:  2001-08       Impact factor: 4.616

Review 6.  Sunitinib in kidney cancer: 10 years of experience and development.

Authors:  Elise Nassif; Constance Thibault; Yann Vano; Laure Fournier; Laetitia Mauge; Virginie Verkarre; Marc-Olivier Timsit; Arnaud Mejean; Eric Tartour; Stéphane Oudard
Journal:  Expert Rev Anticancer Ther       Date:  2016-12-27       Impact factor: 4.512

7.  Changes in the genetic landscape during the malignization of high grade squamous intraepithelial lesion into cervical cancer.

Authors:  Nikolai V Litviakov; M K Ibragimova; M M Tsyganov; O V Shpileva; O N Churuksaeva; L A Kolomiets
Journal:  Curr Probl Cancer       Date:  2020-03-17       Impact factor: 3.187

8.  Combined inhibition of glycolysis, the pentose cycle, and thioredoxin metabolism selectively increases cytotoxicity and oxidative stress in human breast and prostate cancer.

Authors:  Ling Li; Melissa A Fath; Peter M Scarbrough; Walter H Watson; Douglas R Spitz
Journal:  Redox Biol       Date:  2014-12-10       Impact factor: 11.799

Review 9.  Tumour Initiation: a Discussion on Evidence for a "Load-Trigger" Mechanism.

Authors:  John J Evans; Maan M Alkaisi; Peter H Sykes
Journal:  Cell Biochem Biophys       Date:  2019-10-09       Impact factor: 2.194

10.  CancerResource--updated database of cancer-relevant proteins, mutations and interacting drugs.

Authors:  Bjoern-Oliver Gohlke; Janette Nickel; Raik Otto; Mathias Dunkel; Robert Preissner
Journal:  Nucleic Acids Res       Date:  2015-11-20       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.